Sezary Syndrome Latest Advances
Find the Latest Research About Sezary Syndrome
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2234 publications
Successful use of nemolizumab for refractory pruritus in cutaneous T-cell lymphoma.
Journal: JAAD case reports
Published: August 28, 2026
Development of mogamulizumab-associated rash with granuloma annulare-like features in a patient with Sezary syndrome: A case report and review of the literature.
Journal: JAAD case reports
Published: August 20, 2026
Adverse events associated with systemic cutaneous T-cell lymphoma therapies: a narrative review.
Journal: Frontiers in medicine
Published: June 17, 2026
Treatment utilization and outcomes in patients with mycosis fungoides and Sézary syndrome receiving mogamulizumab in community and academic practice in the United States clinical practice.
Journal: Leukemia & lymphoma
Published: June 10, 2026
Cellular and molecular aberrations generating new immunotherapeutic approaches in mycosis fungoides and Sézary syndrome: a comprehensive review of literature.
Journal: Frontiers in immunology
Published: June 03, 2026
GATA3-positivity and T follicular helper phenotype in transformed mycosis fungoides with leukemic involvement and prominent folliculotropism: a case report.
Journal: Frontiers in oncology
Published: May 25, 2026
Sézary Syndrome Biomarker, T Cell Transcription Factors and Cytokine Genes Provide Novel Insight into Response During Mogamulizumab Treatment.
Journal: Cancers
Published: April 14, 2026
Immune-related adverse events with mogamulizumab in cutaneous T-cell lymphoma: A multicentre study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 01, 2026
Psychological Distress, Symptom Burden and Quality of Life in Patients with Mycosis Fungoides and Sézary Syndrome.
Journal: Acta dermato-venereologica
Published: March 03, 2026
Last Updated: 11/08/2026